TOYAMA

Toyama Chemical Co., Ltd.

Application Filed: 1997-05-22
Trademark Application Details
Trademark Logo TOYAMA
800
Live/Registered
REGISTERED AND RENEWED
Research OneLook Acronym Finder
Serial Number75296001
Registration Number2455635
Mark Drawing Code3R21: Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s)
Domestic RepresentativeJEFFREY H KAUFMAN
Attorney NameJEFFREY H KAUFMAN
Attorney Docket Number168862US
Law Office AssignedM10
Employee NameWOOD, CAROLINE

Timeline

1997-05-22Application Filed
1999-09-21Date of First Use
2000-02-01Published for Opposition
2001-05-29Trademark Registered
2011-05-11Location: GENERIC WEB UPDATE
2011-05-11Status: Live/Registered
2011-05-29Renewal Date
2018-07-08Transaction Date

Trademark Applicants & Owners

Owner: TOYAMA CHEMICAL CO., LTD.
AddressNo.2-5, Nishishinjuku 3-chome Shinjuku-ku, Tokyo JP
Legal Entity TypeCorporation
Legal Entity State JP

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Design Search Codes

191325Beakers

Attorney of Record

JEFFREY H KAUFMAN
Oblon, McClelland, Maier & Neustadt, L.L
1940 Duke Street
Alexandria VA 22314

Good, Services, and Codes

International Codes:5
U.S. Codes:006,018,044,046,051,052
Type CodeType
GS0051medicines for human purposes, namely, pharmaceutical preparations for the treatment of the central nervous system, peripheral nervous system, sensory organs, [ allergies, circulatory organs, respiratory organs, digestive organs, urogenital organs or anus, blood, tumors, physical disorders, chemical disorders, parasites; hormones; dermatological medicines; vitamins; dietary supplements in the nature of amino acids; food supplements; medicinal tonics to heal, cleanse, energize and strengthen the body; metabolic medicines; ] antibiotics [ ; pharmaceutical preparations for use in the activation of cells and in chemotherapy; biological medicines, namely, vaccines, nutritional supplements for the stimulation of defensive mechanisms against toxins and toxoids and for the elimination of toxins and toxoids, antitoxins and anti-leptospira serums used for counteracting drugs or other toxic substances for use in poisonings and drug overdoses, and tetanus antitoxins, medical diagnostic reagents used in biological examination; pharmaceutical preparations for use in inducing narcosis; pharmaceutical preparations for use in diagnosis; namely, contrast media for radiography, reagents for function tests, general examination, hematological examination, blood chemistry examination, immuno-serological examination, bacteriological examination, histopathological examination, and radiopharmaceuticals for extrasomatic diagnosis ]

Trademark Filing History

DescriptionDateEvent Coding
ASSIGNED TO EXAMINER1997-12-191 DOCK D:Assigned to Examiner
NON-FINAL ACTION MAILED1997-12-232 CNRT F:First Action
CORRESPONDENCE RECEIVED IN LAW OFFICE1998-06-253 CRFA I:Incoming Correspondence
NON-FINAL ACTION MAILED1998-08-054 CNRT F:First Action
CORRESPONDENCE RECEIVED IN LAW OFFICE1999-02-245 CRFA I:Incoming Correspondence
CORRESPONDENCE RECEIVED IN LAW OFFICE1999-02-246 CRFA I:Incoming Correspondence
FINAL REFUSAL MAILED1999-04-207 CNFR O:Outgoing Correspondence
CORRESPONDENCE RECEIVED IN LAW OFFICE1999-09-308 CRFA I:Incoming Correspondence
APPROVED FOR PUB - PRINCIPAL REGISTER1999-11-299 CNSA P:
NOTICE OF PUBLICATION1999-12-3010 NPUB O:Outgoing Correspondence
PUBLISHED FOR OPPOSITION2000-02-0111 PUBO A:Allowance for Publication
NOA MAILED - SOU REQUIRED FROM APPLICANT2000-04-2512 NOAM O:Outgoing Correspondence
EXTENSION 1 FILED2000-10-0313 EXT1 S:
EXTENSION 1 GRANTED2000-10-0314 EX1G S:
USE AMENDMENT FILED2000-10-0315 IUAF S:
STATEMENT OF USE PROCESSING COMPLETE2000-10-0316 SUPC I:Incoming Correspondence
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED2001-03-0417 CNPR P:
REGISTERED-PRINCIPAL REGISTER2001-05-2918 R.PR A:Allowance for Publication
CASE FILE IN TICRS2006-10-2019 CFIT O:Outgoing Correspondence
PAPER RECEIVED2007-03-1320 MAIL I:Incoming Correspondence
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED2007-03-1321 815F I:Incoming Correspondence
ASSIGNED TO PARALEGAL2007-04-1022 PLGL A:Allowance for Publication
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.2007-04-1623 C15A O:Outgoing Correspondence
TEAS SECTION 8 & 9 RECEIVED2011-04-2224 E89R I:Incoming Correspondence
CASE ASSIGNED TO POST REGISTRATION PARALEGAL2011-05-1125 APRE A:Allowance for Publication
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED2011-05-1126 89AG O:Outgoing Correspondence
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)2011-05-1127 RNL1 Q:
TEAS CHANGE OF CORRESPONDENCE RECEIVED2015-01-2028 TCCA I:Incoming Correspondence
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED2020-05-2929 REM2 E:E-Mail
CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 92021-12-0330 CAEX O:Outgoing Correspondence

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed